Norm-based comparison of the quality-of-life impact of ravulizumab and eculizumab in paroxysmal nocturnal hemoglobinuria.

Schwartz, Carolyn E.

Stark, Roland B.

Borowiec, Katrina.

Nolte, Sandra.

Myren, Karl-Johan.

2021

open in viewer
Description
  • Keywords: Quality of life, Paroxysmal nocturnal hemoglobinuria, Clinical trial, Response shift, Patient-reported outcome, EORTC, Norms, Eculizumab, Ravulizumab.

    Springer Open.
This object is in collection Permanent URL
ID:
b5645578n
To Cite:
TARC Citation Guide    EndNote
Usage:
Detailed Rights